share_log

Wells Fargo Maintains Overweight on Insmed, Maintains $55 Price Target

Moomoo 24/7 ·  Apr 1 12:01

Wells Fargo analyst Tiago Fauth maintains Insmed (NASDAQ:INSM) with a Overweight and maintains $55 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment